Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End. | Front Immunol | 2021 | 34795675 | PubTator, text mining | PubMed |
| Acyl carrier protein promotes MukBEF action in Escherichia coli chromosome organization-segregation. | Nat Commun | 2021 | 34795302 | PubTator, text mining | PubMed |
| Regulatory Roles of Six-Transmembrane Epithelial Antigen of the Prostate Family Members in the Occurrence and Development of Malignant Tumors. | Front Cell Dev Biol | 2021 | 34778263 | PubTator, text mining | PubMed |
| Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC. | Cancers (Basel) | 2021 | 34771735 | PubTator, text mining | PubMed |
| Kinetic Studies of Newly Patented Aminoalkanol Derivatives with Potential Anticancer Activity as Competitive Inhibitors of Prostate Acid Phosphatase. | Int J Mol Sci | 2021 | 34769193 | PubTator, text mining | PubMed |
| Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy. | Front Immunol | 2021 | 34737749 | PubTator, text mining | PubMed |
| A New Generation of Vaccines in the Age of Immunotherapy. | Curr Oncol Rep | 2021 | 34735649 | PubTator, text mining | PubMed |
| Evaluation of Disposable Trap Column nanoLC-FAIMS-MS/MS for the Proteomic Analysis of FFPE Tissue. | J Proteome Res | 2021 | 34735149 | PubTator, text mining | PubMed |
| Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress. | Adv Ther (Weinh) | 2021 | 34734110 | PubTator, text mining | PubMed |
| Therapeutic metastatic prostate cancer vaccines: lessons learnt from urologic oncology. | Cent European J Urol | 2021 | 34729217 | PubTator, text mining | PubMed |
| A behavioral screen for mediators of age-dependent TDP-43 neurodegeneration identifies SF2/SRSF1 among a group of potent suppressors in both neurons and glia. | PLoS Genet | 2021 | 34723963 | PubTator, text mining | PubMed |
| Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform. | Front Oncol | 2021 | 34722273 | PubTator, text mining | PubMed |
| PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going? | Ther Adv Med Oncol | 2021 | 34721674 | PubTator, text mining | PubMed |
| Delivery strategies for cell-based therapies in the brain: overcoming multiple barriers. | Drug Deliv Transl Res | 2021 | 34718958 | PubTator, text mining | PubMed |
| Dual concentration-dependent effect of ascorbic acid on PAP(248-286) amyloid formation and SEVI-mediated HIV infection. | RSC Chem Biol | 2021 | 34704058 | PubTator, text mining | PubMed |
| The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers. | Nanomaterials (Basel) | 2021 | 34685018 | PubTator, text mining | PubMed |
| Characterization of Proteins Regulated by Androgen and Protein Kinase a Signaling in VCaP Prostate Cancer Cells. | Biomedicines | 2021 | 34680521 | PubTator, text mining | PubMed |
| Improved Immunotherapy Efficacy by Vascular Modulation. | Cancers (Basel) | 2021 | 34680355 | PubTator, text mining | PubMed |
| Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going? | Cancers (Basel) | 2021 | 34680214 | PubTator, text mining | PubMed |
| Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis. | Biosci Rep | 2021 | 34677582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=23